Sveriges mest populära poddar
Psychedelics Today
Hälsa och motionMedicin

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

1 tim 4 min•28 juni 2022

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds.

www.psychedelicstoday.com

Fler avsnitt av Psychedelics Today

Visa alla avsnitt av Psychedelics Today
PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture
•1 tim 44 min
PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium
•54 min
PT 654 - Erica Rex - Seeing What Is There
•1 tim 21 min
PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy
•1 tim 19 min
PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow
•1 tim 14 min
PT 651 - Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics
•1 tim 22 min
PT 650 - Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape
•1 tim 7 min
PT 649 - Melissa Lavasani and Jay Kopelman
•1 tim 10 min
PT 648 - Enamory - Couples Therapy with Ketamine
•1 tim 23 min
PT 647 - Joshua White: Fireside Project and Lucy, an AI Training Simulator for Psychedelic Support
•1 tim 11 min

Psychedelics Today med Psychedelics Today finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.